“We entered 2026 with significant momentum that accelerated through Q1, driving a remarkable quarter for Guardant Health.” (CEO)
“Our commercial flywheel has achieved a new level of velocity, delivering our fastest year-over-year percentage revenue growth in the last 5 years and surpassing the $1 billion trailing 12-month revenue milestone.” (CEO)
“Q1 was another strong quarter for Shield... Revenue growth has closely tracked volume growth, reflecting favorable collections and a disciplined focus on reimbursable lives.” (Co-CEO)
“Based on our strong first quarter performance and increased visibility, we are raising our full year 2026 revenue guidance to a range of $1.30 billion to $1.32 billion, representing growth of 32% to 34%.” (CFO)
“We remain focused on disciplined cash management and are on track to decrease full year 2026 free cash flow burn compared to 2025.” (CFO)